Glaxo to Pay Merck Up to $4.2 Billion in Cancer Deal
The Merck KGaA logo stands illuminated at dusk outside the pharmaceutical company’s headquarters in Darmstadt, Germany. (Photographer: Martin Leissl/Bloomberg)

Glaxo to Pay Merck Up to $4.2 Billion in Cancer Deal

(Bloomberg) -- GlaxoSmithKline Plc will pay Germany’s Merck KGaA as much as 3.7 billion euros ($4.2 billion) to get access to a promising immune-oncology treatment that the drugmakers see as a key ...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.